Blockman, MCohen, KDe Waal, RGray, AKredo, TMaartens, GNel, JParrish, ARees, HReubenson, G2025-03-022025-03-022020-06-18Blockman M, Cohen K, De Waal R, Gray A, et al. Chloroquine and hydroxychloroquine for prevention of COVID-19: evidence review of clinical benefits and harms. South African National Department of Health, 2020.http://www.health.gov.za/wp-content/uploads/2020/12/Rapid-review-of-Chloroquine-prophylaxis-for-COVID-19_18June2020.pdfhttps://hdl.handle.net/11288/598222Chloroquine is a medication primarily used to prevent and treat malaria in areas where malaria remains sensitive to its effects. Hydroxychloroquine, sold under the brand name Plaquenil among others, is a medication used to prevent and treat malaria in areas where malaria remains sensitive to chloroquine. Other uses include treatment of rheumatoid arthritis, lupus, and porphyria cutanea tarda.enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/Antimalarial medication4-aminoquinolinePlaquenilDrug therapyCOVID-19Disease controlPharmacyChloroquineHydroxychloroquineTechnical Report